.png)
Ask a VP of Medical Affairs whether their organization has a “data integration problem,” and most say yes without hesitating. Ask what that problem actually is, and the answers scatter — messy HCP records, duplicate KOL entries, a CRM nobody trusts. Those are real problems. They're also not the one costing Medical Affairs the most strategic value.
The bigger problem is quieter: your field team, your advisory boards, and your patient engagement programs are each generating genuine evidence-relevant insight right now, and in most organizations, none of those three sources can see each other. This is the piece that connects them — not by proposing a new database, but by naming what integration actually requires once the insight itself is the thing worth connecting, not just the records describing who generated it.
What "data integration" means for Medical Affairs and what it doesn't
Data integration, in the Medical Affairs context, is the practice of connecting insight generated across different functions and channels — field interactions, advisory boards, patient engagement, external real-world data — so patterns across sources become visible instead of trapped inside whichever tool captured them first.
That's a different problem from Master Data Management (MDM), which solves entity resolution: making sure “Dr. Sarah Chen at Memorial Hospital” is recognized as the same person across your CRM, your claims data, and your publication database. MDM matters, and most organizations already have a workstream for it. It does not, on its own, tell you that a concern a KOL raised on an advisory board last quarter and a concern a different KOL raised to an MSL in the field last month are describing the same evidence gap. That's a semantic problem, not an identity-resolution problem — and it's the one this piece is actually about.
It's also worth being direct about what this isn't: a pitch for ripping out existing systems. Most of the fragmentation Medical Affairs deals with isn't a technology failure. It's the absence of a shared way to classify insight once it's captured, regardless of which system captured it.
The four data layers every Medical Affairs organization generates
Nearly every Medical Affairs organization already generates four distinct layers of insight. The problem isn't a missing layer — it's that they rarely talk to each other.
| Layer | Who generates it | Where it typically lives | What's lost when isolated |
|---|---|---|---|
| External RWD | EHRs, claims, registries, wearables | Licensed by HEOR or a data science team | Never compared against what the field is hearing in real time |
| Field / MSL insight | MSLs in HCP and KOL conversations | CRM free-text fields, trip reports | Buried in unstructured notes; patterns across regions invisible |
| Advisory board insight | Structured, compensated expert input | A single-purpose advisory board platform | Read once in a PDF report, never compared to field insight on the same topic |
| Patient / PRO insight | Patient advisors, PRO instruments | Patient engagement or commercial reports | Treated as sentiment, not evidence; rarely reaches MSLs or HEOR |
Each layer, examined alone, looks reasonably well-managed. The cost shows up in the gaps between them. A real-world evidence program that only draws on external RWD is missing the “why” that field insight would supply. A virtual advisory board that generates a sharp clinical insight has no way to check whether three MSLs heard the same thing last month. A patient-centric engagement program collecting real PRO data has no path to reach the MSL having a scientific exchange with an HCP about the same symptom burden next week.
None of these gaps show up as an error message. They show up as a study that gets scoped eight months later than it could have, because the pattern that would have justified it sooner was split across three systems that never compared notes.
What actually integrating these layers requires
Fixing this doesn't start with a data warehouse project. It starts with a shared taxonomy — a consistent way of tagging insight, regardless of source, so that a field observation and an advisory board finding on the same topic land in the same bucket.
A working taxonomy needs four dimensions applied consistently across every layer:
- Therapeutic area — the disease state or product line the insight relates to.
- Evidence-gap type — what kind of question this is (efficacy, safety, adherence, access, unmet need).
- Stakeholder source — HCP KOL, patient advisor, MSL field observation, external RWD.
- Confidence and frequency — how many independent sources have raised this, and how directly.
Getting this right is a governance question as much as a technical one. The taxonomy needs a cross-functional owner — typically Medical Affairs and HEOR jointly, with Compliance signing off on how patient- and HCP-sourced insight is handled differently. Without a named owner, taxonomies drift: one region tags “adherence” concerns differently than another, and the pattern-matching that justified this whole exercise quietly breaks.
The platform question matters, but it's secondary to the taxonomy question. A Medical Affairs CRM that applies one taxonomy across field, advisory board, and patient insight makes the pattern visible automatically. The same four data layers sitting in four well-run but disconnected tools will never surface the pattern, no matter how good each individual tool is. This is also where scientific exchange becomes a genuine data source rather than just a compliance category — every compliant MSL-KOL conversation is a potential insight, and it should be captured with the same rigor as everything else.
What good looks like
Fictional composite example. A mid-size immunology-focused biotech — call it Solvane Therapeutics — unifies its insight taxonomy across three previously separate systems: its advisory board platform, its MSL CRM, and a spreadsheet its patient engagement team used to log advisor calls. Within the first quarter, a taxonomy-driven query surfaces a cluster of fourteen insights — six field-captured, five from a patient advisory board, three from an HCP advisory board — all describing the same unaddressed comorbidity concern, none of which had previously been connected because they lived in three different places. Medical Affairs scopes a real-world evidence study directly from that cluster. The insight existed the whole time. What changed was whether the organization could see it as one signal instead of three unrelated ones.
See how one taxonomy runs across field, advisory board, and patient insight in practice — capture, tagging, and the cross-source pattern view in one platform.
See TikaInsights in a 20-minute walkthroughKey questions Medical Affairs leaders ask about data integration
Isn't this just Master Data Management with a different name?
No — they solve different problems and both are usually needed. MDM answers “is this the same HCP record across our systems.” Insight integration answers “are these three different insights, from three different sources, describing the same underlying evidence gap.” An organization can have excellent MDM and still have zero visibility into cross-source insight patterns, because that's not what MDM is built to do.
Where should we start if we're integrating insight for the first time?
Start with the taxonomy, not the technology. Define your evidence-gap categories, therapeutic area structure, and stakeholder-source tags before evaluating any platform. Most integration projects that start with a tool purchase end up forcing data into a structure nobody agreed on; starting with the taxonomy means the tool decision becomes much easier because you know exactly what it needs to support.
Who should own the shared taxonomy?
Joint ownership between Medical Affairs and HEOR works best in practice, with Compliance involved specifically for how patient-sourced and HCP-sourced insight are labeled and handled differently. A taxonomy owned by a single function tends to drift toward that function's priorities and loses relevance for the others.
Does integrating advisory board and patient insight into the same system raise compliance concerns?
It requires care, not avoidance. HCP advisory board data, MSL field insight, and patient-sourced insight each carry different consent, disclosure, and handling requirements. Unifying the taxonomy that classifies the insight doesn't mean flattening those distinctions — the system needs to preserve source-specific compliance handling while still allowing the content to be compared thematically.
How do we know if fragmentation is actually costing us anything measurable?
Look at time-to-scope: how long does it take from when the first hint of an evidence gap appears somewhere in your organization to when a study or scientific narrative addresses it. Organizations with fragmented insight typically can't even answer this question, because no one system has the full timeline. That inability to answer is itself the diagnostic.
The organizations getting real value from their data in 2026 aren't the ones with the most systems. They're the ones where an insight can be recognized as the same insight, no matter which of the four layers it came from.
See how field, advisory board, and patient insight connect in one taxonomy with TikaMobile Medical Insights.
Book a 20-minute demo.png)
-2.png)